4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-25-020803
Chief Financial Officer gave up 203 shares (to pay taxes)
- Chief Financial Officer acquired 833 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Foster Jonathan P. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-16 | Exercise or conversion : show line 1 in the form | +833 | 12,196 | D | ||
| 2025-06-16 | Shares withheld for taxes : show line 2 in the form | −203 | $0.69 | $139 | 11,993 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-16 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −833 | 230,684 | D |
Loading xslF345X05/rdgdoc.xml…